• 

  TSRC 2026

  FROM CONCEPT TO COMPLIANCE: NAVIGATING THE REGULATORY PATHWAY FOR ORAL NICOTINE POUCHES TO BE LICENSED AS NICOTINE REPLACEMENT THERAPY IN CANADA
• 

  TSRC 2026

  Machine Learning Identification of Product Attributes Associated with Nicotine Pharmacokinetics Under Controlled Use Conditions
• 

  TSRC 2026

  AI‑BASED NICOTINE PHARMACOKINETIC PREDICTION TO SUPPORT PRODUCT DEVELOPMENT AND REGULATORY DECISION-MAKING
• 

  TSRC 2025

  WHERE POPULATION-LEVEL HEALTH BENEFIT IS OFTEN FORGOTTEN
• 

  TSRC 2025

  Optimizing abuse liability studies for FDA review of novel nicotine products
• 

  TSRC 2025

  Who are the users of Nic Nac nicotine lozenges?

Previous123Next